Bausch & Lomb metipranolol HCl
Executive Summary
No launch date or price has been set for the ophthalmic beta-blocker, which was approved Dec. 29. B&L plans to drop tradename used in the NDA, Betamet, and has not yet selected a new one. In the Jan. 1 "The Pink Sheet" (pp. 1 & 18), Pharmaquest, B&L's agent in preparing the NDA, was mistakenly identified as the metipranolol sponsor.